Skip to main content
LIFE

FEMTHERAPEUTICS

A gynecological platform for personalized and non-invasive prosthetics for women

IF WE create a gynecological platform for personalized and non-invasive prosthetics, can we customize pelvic medicine for women?

FemTherapeutics provides a long-term, sustainable solution to the challenges facing women's health. On health by offering personalized, non-invasive prosthetics that adapt to each woman's unique anatomy, improving comfort and reducing the need for high-risk surgeries. On gender equality by building the largest dataset on female pelvic floor health, advancing research and reducing stigma around conditions like prolapse and incontinence. On environment by promoting reusable and sustainable production processed medical devices that reduce waste. On economy by creating cost-effective, innovative solutions that improve quality of life for women at every stage, from menstruation to menopause.

JOIN THE COMMUNITY

WHY THIS PROJECT ?

This project was born from the realization that women's health has been neglected for decades. Current gynecological solutions are often standardized, available in a limited number of shapes and sizes, and uncomfortable for long-term use. For example, pessaries, which are used to treat pelvic organ prolapse, are mass-produced with simple geometric shapes and fail in 50% of cases, causing erosions, lacerations, and falling out of the vaginal canal. The Team aims to address these issues by offering a more effective, customized solution that adapts to the unique anatomy of each patient.

 

THE MISSION

The mission of FemTherapeutics is to personalize pelvic medicine for women. The team aims to achieve this by providing non-invasive, customized gynecological prosthetics at every stage of a woman's life, from menstruation to menopause. The goal is to reinvent women's health by offering personalized and non-invasive solutions for common gynecological conditions.

 

THEIR VALUES

Fem Therapeutics focuses on enhancing women's health through personalized, non-invasive solutions. Here are their key values, summarized:

-Effectiveness and Non-Invasiveness: Providing alternatives to surgical interventions, improving comfort and quality of life.

-Gender Equality: Bridging the gap in healthcare by focusing on women's specific needs and combating stigma.

-Sustainability: Reducing environmental impact by using biodegradable materials and promoting device reuse.

-Personalization: Creating solutions tailored to each woman's unique anatomy, rather than one-size-fits-all products.

-Innovation: Leveraging cutting-edge technologies like AI, cloud computing, and 3D printing to develop advanced solutions.

-Patient-Centric Approach: Prioritizing patient needs and experiences, addressing discomfort, and empowering women to regain control over their bodies.

-Collaboration with Clinicians: Will be providing a digital platform to facilitate decision-making and improve clinical workflow.

 

 

A DISRUPTIVE INNOVATION

The disruptive idea of FemTherapeutics is to create the world's first gynecological platform for customized non-invasive prosthetics. The plan is to use an exclusive measurement tool to obtain measurements of the vaginal canal and then use software to design a personalized pessary that will be 3D-printed with medical-grade silicone. Patients and clinicians will also have access to a digital platform to track clinical outcomes. This personalized approach will allow the creation of pessaries that provide dynamic support, are easy to insert and remove, and are more likely to stay in place.

Modelization of a prosthetic

 

 

POSITIVE IMPACT ON THE SOCIETY

 

 

FemTherapeutics is committed to having a positive impact on society in several ways:

SDG 3 : Providing effective non-invasive solutions that can serve as an alternative to high-risk surgical interventions.

SDG 5 : Reducing gender inequalities by building the first and largest dataset on female pelvic floor health. This data will advance research and development and help reduce the stigma associated with prolapse and incontinence.

SDG 12 : Offering sustainable processed solutions and promoting reusable devices to reduce waste.

 

LEVERAGING THE 3DEXPERIENCE PLATFORM

 

 

-To iterate the design of their pessary to achieve design freeze.

-To further develop their parametric designs using CATIA.

-To facilitate their clinical trials through the Medidata application. Medidata will provide a clinical development platform that will help them connect with patients during clinical trials.

 

COLLABORATIVE & COLLECTIVE INTELLIGENCE

-The Team has previously partnered with the Mayo Clinic to enhance their predictive models.

-They will work with healthcare providers to tailor and measure devices for each patient. Clinicians will use FemTherapeutics' exclusive measurement tool to obtain the patient's vaginal canal measurements, which will then be used to design a personalized pessary.

-The Team aims to create a community for patients to share testimonials and information. This community will provides support and information to women suffering from pelvic floor disorders and helps reduce the stigma associated with these conditions.

-By leveraging the expertise of various stakeholders, FemTherapeutics can improve its products, better understand patients' needs, and create an engaged community around pelvic health.

  • Inara Lalani, BCom
    Inara Lalani, BCom
    Chief Executive Officer & Co-Founder
  • Mihnea Gangal, M.D.
    Mihnea Gangal, M.D.
    Chief Medical Officer & Co-Founder
  • Negin Ashouri, MSc.
    Negin Ashouri, MSc.
    Chief Technology Officer & Co-Founder

Submit your project

Do you think your project is the next big thing?
Join the team !

Submit your project